Raffaella Barone

Suggest Changes
Learn More
The pharmacokinetics and dosimetry of 86Y-DOTA0-d-Phe1-Tyr3-octreotide (86Y-SMT487) were evaluated in a phase I positron emission tomography (PET) study of 24 patients with somatostatin(More)
The aim of this study was to retrospectively evaluate whether the red marrow (RM) takes up 111In-diethylenetriaminepentaacetic acid (DTPA)-D-Phe1-octreotide and 86Y-DOTATOC and to assess the(More)